BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 27997968)

  • 1. The Microbiome and the Liver: The Basics.
    Victor DW; Quigley EM
    Semin Liver Dis; 2016 Sep; 36(4):299-305. PubMed ID: 27997968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiota and liver diseases.
    Minemura M; Shimizu Y
    World J Gastroenterol; 2015 Feb; 21(6):1691-702. PubMed ID: 25684933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis.
    Giannelli V; Di Gregorio V; Iebba V; Giusto M; Schippa S; Merli M; Thalheimer U
    World J Gastroenterol; 2014 Dec; 20(45):16795-810. PubMed ID: 25492994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiota and host metabolism in liver cirrhosis.
    Usami M; Miyoshi M; Yamashita H
    World J Gastroenterol; 2015 Nov; 21(41):11597-608. PubMed ID: 26556989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of artesunate supplementation on bacterial translocation and dysbiosis of gut microbiota in rats with liver cirrhosis.
    Chen YX; Lai LN; Zhang HY; Bi YH; Meng L; Li XJ; Tian XX; Wang LM; Fan YM; Zhao ZF; Han DW; Ji C
    World J Gastroenterol; 2016 Mar; 22(10):2949-59. PubMed ID: 26973391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alcoholic liver disease: the gut microbiome and liver cross talk.
    Hartmann P; Seebauer CT; Schnabl B
    Alcohol Clin Exp Res; 2015 May; 39(5):763-75. PubMed ID: 25872593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Microbiome in Primary Sclerosing Cholangitis: Current Evidence and Potential Concepts.
    Hov JR; Karlsen TH
    Semin Liver Dis; 2017 Nov; 37(4):314-331. PubMed ID: 29272894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host-microbiome interactions in alcoholic liver disease.
    Chen P; Schnabl B
    Gut Liver; 2014 May; 8(3):237-41. PubMed ID: 24827618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonalcoholic fatty liver disease: for better or worse, blame the gut microbiota?
    Li DY; Yang M; Edwards S; Ye SQ
    JPEN J Parenter Enteral Nutr; 2013 Nov; 37(6):787-93. PubMed ID: 23538296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathways and functions of gut microbiota metabolism impacting host physiology.
    Krishnan S; Alden N; Lee K
    Curr Opin Biotechnol; 2015 Dec; 36():137-45. PubMed ID: 26340103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Intestinal Microbiome and the Liver Transplant Recipient: What We Know and What We Need to Know.
    Doycheva I; Leise MD; Watt KD
    Transplantation; 2016 Jan; 100(1):61-8. PubMed ID: 26647107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantifying Diet-Induced Metabolic Changes of the Human Gut Microbiome.
    Shoaie S; Ghaffari P; Kovatcheva-Datchary P; Mardinoglu A; Sen P; Pujos-Guillot E; de Wouters T; Juste C; Rizkalla S; Chilloux J; Hoyles L; Nicholson JK; ; Dore J; Dumas ME; Clement K; Bäckhed F; Nielsen J
    Cell Metab; 2015 Aug; 22(2):320-31. PubMed ID: 26244934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiota-related complications in cirrhosis.
    Gómez-Hurtado I; Such J; Sanz Y; Francés R
    World J Gastroenterol; 2014 Nov; 20(42):15624-31. PubMed ID: 25400446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut-liver axis and probiotics: their role in non-alcoholic fatty liver disease.
    Paolella G; Mandato C; Pierri L; Poeta M; Di Stasi M; Vajro P
    World J Gastroenterol; 2014 Nov; 20(42):15518-31. PubMed ID: 25400436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early life dynamics of the human gut virome and bacterial microbiome in infants.
    Lim ES; Zhou Y; Zhao G; Bauer IK; Droit L; Ndao IM; Warner BB; Tarr PI; Wang D; Holtz LR
    Nat Med; 2015 Oct; 21(10):1228-34. PubMed ID: 26366711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut-liver axis in alcoholic liver disease.
    Szabo G
    Gastroenterology; 2015 Jan; 148(1):30-6. PubMed ID: 25447847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrointestinal and hepatic mechanisms limiting entry and dissemination of lipopolysaccharide into the systemic circulation.
    Guerville M; Boudry G
    Am J Physiol Gastrointest Liver Physiol; 2016 Jul; 311(1):G1-G15. PubMed ID: 27151941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Gut Microbiota in Liver Disease.
    Brenner DA; Paik YH; Schnabl B
    J Clin Gastroenterol; 2015; 49 Suppl 1(0 1):S25-7. PubMed ID: 26447960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota imbalance and colorectal cancer.
    Gagnière J; Raisch J; Veziant J; Barnich N; Bonnet R; Buc E; Bringer MA; Pezet D; Bonnet M
    World J Gastroenterol; 2016 Jan; 22(2):501-18. PubMed ID: 26811603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of metagenomics in the human gut microbiome.
    Wang WL; Xu SY; Ren ZG; Tao L; Jiang JW; Zheng SS
    World J Gastroenterol; 2015 Jan; 21(3):803-14. PubMed ID: 25624713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.